To: Board of County Commissioners
From: Joshua Freeman, Director of Administration
title
RE: Closed Session to discuss trial or settlement strategy with manufacturer defendants Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus in the matter of County of Genesee v Purdue Pharma L.P., et al, U.S. District Court case no. 17-cv-14074
recommendation
BOARD ACTION REQUESTED:
Closed Session to discuss trial or settlement strategy with manufacturer defendants Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus in the matter of County of Genesee v Purdue Pharma L.P., et al, U.S. District Court case no. 17-cv-14074
BACKGROUND:
DISCUSSION:
IMPACT ON HUMAN RESOURCES:
IMPACT ON BUDGET:
IMPACT ON FACILITIES:
IMPACT ON TECHNOLOGY:
CONFORMITY TO COUNTY PRIORITIES:
TO THE HONORABLE CHAIRPERSON AND MEMBERS OF THE GENESEE COUNTY BOARD OF COMMISSIONERS, GENESEE COUNTY, MICHIGAN
LADIES AND GENTLEMEN:
WHEREAS, in 2017, this Board of County Commissioners of Genesee County, Michigan, authorized filing a lawsuit to address the public nuisance that is the Opioid Epidemic; and
WHEREAS the following entities:
1. Alvogen Inc.,
2. Amneal Pharmaceuticals, Inc.,
3. Apotex Inc.,
4. Hikma Pharmaceuticals USA, Inc.,
5. Indivior Inc.,
6. Mylan Pharmaceuticals Inc.,
7. Sun Pharmaceutical Industries, Inc., and
8. Zydus Pharmaceuticals, Inc.,
("Settling Defendants") have negotiated proposed national settlement agreements ("Proposed Settlements") with the State Attorneys General, and a Plaintiff Executive Committee-designated negotiating committee that represents approximately 4,000 local governments that have brought lawsuits similar to Genesee County's lawsuit; and
WHEREAS the Proposed Settlements contain significant equitable and monetary relief, including:
1. An agreement to pay (a) $18,680,162 in a single year by Alvogen Inc.; (b) $71,751,010 over ten years by Amneal Pharmaceuticals, Inc.; (c) $63,682,369 in a single year by Apotex ...
Click here for full text